Mario Leutert

Mario Leutert is a Senior Scientist at Roche's pRED 360 Labs, specializing in mass spectrometry-based proteomics and drug discovery. With over 10 years of experience in biomedical research, Mario has a deep understanding of experimental and computational proteomics, cancer biology, and immune biology. They earned a Ph.D. in Molecular Life Sciences from the University of Zurich, where they developed significant methodologies for identifying protein modifications related to DNA damage responses. Throughout their career, Mario has contributed to multiple high-impact publications and successfully mentored junior researchers while managing cross-disciplinary projects.